Stoke Therapeutics Inc (STOK)
13.90
-0.13
(-0.93%)
USD |
NASDAQ |
May 17, 16:00
13.90
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics Cash and Short Term Investments (Quarterly): 178.58M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 178.58M |
| December 31, 2023 | 201.39M |
| September 30, 2023 | 214.72M |
| June 30, 2023 | 231.45M |
| March 31, 2023 | 253.67M |
| December 31, 2022 | 229.60M |
| September 30, 2022 | 251.66M |
| June 30, 2022 | 275.63M |
| March 31, 2022 | 293.22M |
| December 31, 2021 | 219.81M |
| September 30, 2021 | 236.16M |
| Date | Value |
|---|---|
| June 30, 2021 | 251.23M |
| March 31, 2021 | 267.51M |
| December 31, 2020 | 287.31M |
| September 30, 2020 | 191.46M |
| June 30, 2020 | 201.93M |
| March 31, 2020 | 211.29M |
| December 31, 2019 | 222.47M |
| September 30, 2019 | 233.05M |
| June 30, 2019 | 242.68M |
| March 31, 2019 | 98.65M |
| December 31, 2018 | 105.40M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
178.58M
Minimum
Mar 2024
293.22M
Maximum
Mar 2022
234.74M
Average
232.25M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 12.57M |
| iBio Inc | 2.788M |
| Actinium Pharmaceuticals Inc | 84.06M |
| Lixte Biotechnology Holdings Inc | 3.414M |
| Fate Therapeutics Inc | 383.54M |